Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial - Bovill, EG; Terrin, ML; Stump, DC (Ann Intern Med, 1991)